Skip to main content
Premium Trial:

Request an Annual Quote

Quidel Gets FDA OK for Flu Assay on Cepheid System

NEW YORK (GenomeWeb News) – Quidel said today that it has received 510(k) clearance from the US Food and Drug Administration for its Quidel Molecular Influenza A+B assay for use with the Cepheid SmartCycler PCR system.

Quidel received FDA clearance for the same assay in December for use on Life Technologies' ABI 7500 Fast Dx thermal cycler.

Quidel launched the Influenza A+B assay in Europe for use with both the SmartCycler and 7500 Fast in August after receiving the CE-IVD Mark.

The Quidel Molecular product line offers PCR reagent kits for use by molecular diagnostic laboratories with their existing thermocyclers. The kits include "unique features that provide for simple transport and storage, ease of use, an attractive workflow, a short time to result, and other benefits that favorably affect diagnostic test outcome," the San Diego-based company said in a statement.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.